Ten Years’ Experience With Continuous Ambulatory Peritoneal Dialysis
Up to January 1989, 171 patients were trained at our center on continuous ambulatory peritoneal dialysis (CAPD), and 17 on continuous cyclic peritoneal dialysis (CCPD). Over 10 years, we have gained 5,068 patient-months experience. Patient survival was 60% and 31% at 5 and 10 years, respectively. In...
Gespeichert in:
| Veröffentlicht in: | American journal of kidney diseases 1991-02, Vol.17 (2), p.158-164 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 164 |
|---|---|
| container_issue | 2 |
| container_start_page | 158 |
| container_title | American journal of kidney diseases |
| container_volume | 17 |
| creator | Rotellar, Carlos Black, John Winchester, James F. Rakowski, Thomas A. Mosher, Winnie F. Mazzoni, Mary Jane Amiranzavi, Marylynn Garagusi, Vincent Alijani, Mohammad R. Argy, William P. |
| description | Up to January 1989, 171 patients were trained at our center on continuous ambulatory peritoneal dialysis (CAPD), and 17 on continuous cyclic peritoneal dialysis (CCPD). Over 10 years, we have gained 5,068 patient-months experience. Patient survival was 60% and 31% at 5 and 10 years, respectively. In contrast, diabetics had a survival of 32% at 5 years. Major complications included 499 new episodes of peritonitis, 304 exit-site infections, 22 hernias, five bowel perforations, one hydrothorax, and three episodes of sclerosing encapsulating peritonitis. Our technique survival has been 62% and 40% at 5 and 10 years, respectively. We believe that CAPD is a viable dialysis technique for long-term treatment of chronic renal failure and it should be offered as an option to intermittent hemodialysis. |
| doi_str_mv | 10.1016/S0272-6386(12)81122-X |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80443693</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S027263861281122X</els_id><sourcerecordid>80443693</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351x-579995b56e9194afee3e51529c9fabd07214ddcc2c402f070d5d0c36daba1ed23</originalsourceid><addsrcrecordid>eNqFkMtKxDAUhoMo43h5BKELEV1Uc2nSZiXDeAVBQcVxFdLkFCOddkxacXa-hq_nk9iZDrp0dRbn-8_5-RDaI_iYYCJO7jFNaSxYJg4JPcoIoTSerKEh4ZTFImPZOhr-IptoK4RXjLFkQgzQgEhJBRdDdPEAVfQM2ofvz6_o_GMG3kFlIHpyzUs0rqvGVW3dhmg0zdtSN7WfR3cd09QV6DI6c7qcBxd20EahywC7q7mNHi_OH8ZX8c3t5fV4dBMbxslHzFMpJc-5AElkogsABrwrLI0sdG5xSklirTHUJJgWOMWWW2yYsDrXBCxl2-igvzvz9VsLoVFTFwyUpa6ga6kynCRMSNaBvAeNr0PwUKiZd1Pt54pgtfCnlv7UQo4iVC39qUmX21s9aPMp2L9UL6zb76_2OhhdFl5XxoVfjGOaZOmi52mPQSfj3YFXwSy9WufBNMrW7p8iP7UXjdU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80443693</pqid></control><display><type>article</type><title>Ten Years’ Experience With Continuous Ambulatory Peritoneal Dialysis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Rotellar, Carlos ; Black, John ; Winchester, James F. ; Rakowski, Thomas A. ; Mosher, Winnie F. ; Mazzoni, Mary Jane ; Amiranzavi, Marylynn ; Garagusi, Vincent ; Alijani, Mohammad R. ; Argy, William P.</creator><creatorcontrib>Rotellar, Carlos ; Black, John ; Winchester, James F. ; Rakowski, Thomas A. ; Mosher, Winnie F. ; Mazzoni, Mary Jane ; Amiranzavi, Marylynn ; Garagusi, Vincent ; Alijani, Mohammad R. ; Argy, William P.</creatorcontrib><description>Up to January 1989, 171 patients were trained at our center on continuous ambulatory peritoneal dialysis (CAPD), and 17 on continuous cyclic peritoneal dialysis (CCPD). Over 10 years, we have gained 5,068 patient-months experience. Patient survival was 60% and 31% at 5 and 10 years, respectively. In contrast, diabetics had a survival of 32% at 5 years. Major complications included 499 new episodes of peritonitis, 304 exit-site infections, 22 hernias, five bowel perforations, one hydrothorax, and three episodes of sclerosing encapsulating peritonitis. Our technique survival has been 62% and 40% at 5 and 10 years, respectively. We believe that CAPD is a viable dialysis technique for long-term treatment of chronic renal failure and it should be offered as an option to intermittent hemodialysis.</description><identifier>ISSN: 0272-6386</identifier><identifier>EISSN: 1523-6838</identifier><identifier>DOI: 10.1016/S0272-6386(12)81122-X</identifier><identifier>PMID: 1992656</identifier><language>eng</language><publisher>Orlando, FL: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Diabetic Nephropathies - mortality ; Diabetic Nephropathies - therapy ; Emergency and intensive care: renal failure. Dialysis management ; Female ; Humans ; Intensive care medicine ; Kidney Failure, Chronic - etiology ; Kidney Failure, Chronic - mortality ; Kidney Failure, Chronic - therapy ; Male ; Medical sciences ; Middle Aged ; Peritoneal Dialysis, Continuous Ambulatory - adverse effects ; Peritonitis - etiology ; Peritonitis - microbiology ; Retrospective Studies</subject><ispartof>American journal of kidney diseases, 1991-02, Vol.17 (2), p.158-164</ispartof><rights>1991 National Kidney Foundation, Inc.</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c351x-579995b56e9194afee3e51529c9fabd07214ddcc2c402f070d5d0c36daba1ed23</citedby><cites>FETCH-LOGICAL-c351x-579995b56e9194afee3e51529c9fabd07214ddcc2c402f070d5d0c36daba1ed23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S027263861281122X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5024872$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1992656$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rotellar, Carlos</creatorcontrib><creatorcontrib>Black, John</creatorcontrib><creatorcontrib>Winchester, James F.</creatorcontrib><creatorcontrib>Rakowski, Thomas A.</creatorcontrib><creatorcontrib>Mosher, Winnie F.</creatorcontrib><creatorcontrib>Mazzoni, Mary Jane</creatorcontrib><creatorcontrib>Amiranzavi, Marylynn</creatorcontrib><creatorcontrib>Garagusi, Vincent</creatorcontrib><creatorcontrib>Alijani, Mohammad R.</creatorcontrib><creatorcontrib>Argy, William P.</creatorcontrib><title>Ten Years’ Experience With Continuous Ambulatory Peritoneal Dialysis</title><title>American journal of kidney diseases</title><addtitle>Am J Kidney Dis</addtitle><description>Up to January 1989, 171 patients were trained at our center on continuous ambulatory peritoneal dialysis (CAPD), and 17 on continuous cyclic peritoneal dialysis (CCPD). Over 10 years, we have gained 5,068 patient-months experience. Patient survival was 60% and 31% at 5 and 10 years, respectively. In contrast, diabetics had a survival of 32% at 5 years. Major complications included 499 new episodes of peritonitis, 304 exit-site infections, 22 hernias, five bowel perforations, one hydrothorax, and three episodes of sclerosing encapsulating peritonitis. Our technique survival has been 62% and 40% at 5 and 10 years, respectively. We believe that CAPD is a viable dialysis technique for long-term treatment of chronic renal failure and it should be offered as an option to intermittent hemodialysis.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Diabetic Nephropathies - mortality</subject><subject>Diabetic Nephropathies - therapy</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Female</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Kidney Failure, Chronic - etiology</subject><subject>Kidney Failure, Chronic - mortality</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Peritoneal Dialysis, Continuous Ambulatory - adverse effects</subject><subject>Peritonitis - etiology</subject><subject>Peritonitis - microbiology</subject><subject>Retrospective Studies</subject><issn>0272-6386</issn><issn>1523-6838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtKxDAUhoMo43h5BKELEV1Uc2nSZiXDeAVBQcVxFdLkFCOddkxacXa-hq_nk9iZDrp0dRbn-8_5-RDaI_iYYCJO7jFNaSxYJg4JPcoIoTSerKEh4ZTFImPZOhr-IptoK4RXjLFkQgzQgEhJBRdDdPEAVfQM2ofvz6_o_GMG3kFlIHpyzUs0rqvGVW3dhmg0zdtSN7WfR3cd09QV6DI6c7qcBxd20EahywC7q7mNHi_OH8ZX8c3t5fV4dBMbxslHzFMpJc-5AElkogsABrwrLI0sdG5xSklirTHUJJgWOMWWW2yYsDrXBCxl2-igvzvz9VsLoVFTFwyUpa6ga6kynCRMSNaBvAeNr0PwUKiZd1Pt54pgtfCnlv7UQo4iVC39qUmX21s9aPMp2L9UL6zb76_2OhhdFl5XxoVfjGOaZOmi52mPQSfj3YFXwSy9WufBNMrW7p8iP7UXjdU</recordid><startdate>199102</startdate><enddate>199102</enddate><creator>Rotellar, Carlos</creator><creator>Black, John</creator><creator>Winchester, James F.</creator><creator>Rakowski, Thomas A.</creator><creator>Mosher, Winnie F.</creator><creator>Mazzoni, Mary Jane</creator><creator>Amiranzavi, Marylynn</creator><creator>Garagusi, Vincent</creator><creator>Alijani, Mohammad R.</creator><creator>Argy, William P.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199102</creationdate><title>Ten Years’ Experience With Continuous Ambulatory Peritoneal Dialysis</title><author>Rotellar, Carlos ; Black, John ; Winchester, James F. ; Rakowski, Thomas A. ; Mosher, Winnie F. ; Mazzoni, Mary Jane ; Amiranzavi, Marylynn ; Garagusi, Vincent ; Alijani, Mohammad R. ; Argy, William P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351x-579995b56e9194afee3e51529c9fabd07214ddcc2c402f070d5d0c36daba1ed23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Diabetic Nephropathies - mortality</topic><topic>Diabetic Nephropathies - therapy</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Female</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Kidney Failure, Chronic - etiology</topic><topic>Kidney Failure, Chronic - mortality</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Peritoneal Dialysis, Continuous Ambulatory - adverse effects</topic><topic>Peritonitis - etiology</topic><topic>Peritonitis - microbiology</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rotellar, Carlos</creatorcontrib><creatorcontrib>Black, John</creatorcontrib><creatorcontrib>Winchester, James F.</creatorcontrib><creatorcontrib>Rakowski, Thomas A.</creatorcontrib><creatorcontrib>Mosher, Winnie F.</creatorcontrib><creatorcontrib>Mazzoni, Mary Jane</creatorcontrib><creatorcontrib>Amiranzavi, Marylynn</creatorcontrib><creatorcontrib>Garagusi, Vincent</creatorcontrib><creatorcontrib>Alijani, Mohammad R.</creatorcontrib><creatorcontrib>Argy, William P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of kidney diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rotellar, Carlos</au><au>Black, John</au><au>Winchester, James F.</au><au>Rakowski, Thomas A.</au><au>Mosher, Winnie F.</au><au>Mazzoni, Mary Jane</au><au>Amiranzavi, Marylynn</au><au>Garagusi, Vincent</au><au>Alijani, Mohammad R.</au><au>Argy, William P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ten Years’ Experience With Continuous Ambulatory Peritoneal Dialysis</atitle><jtitle>American journal of kidney diseases</jtitle><addtitle>Am J Kidney Dis</addtitle><date>1991-02</date><risdate>1991</risdate><volume>17</volume><issue>2</issue><spage>158</spage><epage>164</epage><pages>158-164</pages><issn>0272-6386</issn><eissn>1523-6838</eissn><abstract>Up to January 1989, 171 patients were trained at our center on continuous ambulatory peritoneal dialysis (CAPD), and 17 on continuous cyclic peritoneal dialysis (CCPD). Over 10 years, we have gained 5,068 patient-months experience. Patient survival was 60% and 31% at 5 and 10 years, respectively. In contrast, diabetics had a survival of 32% at 5 years. Major complications included 499 new episodes of peritonitis, 304 exit-site infections, 22 hernias, five bowel perforations, one hydrothorax, and three episodes of sclerosing encapsulating peritonitis. Our technique survival has been 62% and 40% at 5 and 10 years, respectively. We believe that CAPD is a viable dialysis technique for long-term treatment of chronic renal failure and it should be offered as an option to intermittent hemodialysis.</abstract><cop>Orlando, FL</cop><pub>Elsevier Inc</pub><pmid>1992656</pmid><doi>10.1016/S0272-6386(12)81122-X</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0272-6386 |
| ispartof | American journal of kidney diseases, 1991-02, Vol.17 (2), p.158-164 |
| issn | 0272-6386 1523-6838 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_80443693 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adolescent Adult Aged Aged, 80 and over Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Diabetic Nephropathies - mortality Diabetic Nephropathies - therapy Emergency and intensive care: renal failure. Dialysis management Female Humans Intensive care medicine Kidney Failure, Chronic - etiology Kidney Failure, Chronic - mortality Kidney Failure, Chronic - therapy Male Medical sciences Middle Aged Peritoneal Dialysis, Continuous Ambulatory - adverse effects Peritonitis - etiology Peritonitis - microbiology Retrospective Studies |
| title | Ten Years’ Experience With Continuous Ambulatory Peritoneal Dialysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T02%3A50%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ten%20Years%E2%80%99%20Experience%20With%20Continuous%20Ambulatory%20Peritoneal%20Dialysis&rft.jtitle=American%20journal%20of%20kidney%20diseases&rft.au=Rotellar,%20Carlos&rft.date=1991-02&rft.volume=17&rft.issue=2&rft.spage=158&rft.epage=164&rft.pages=158-164&rft.issn=0272-6386&rft.eissn=1523-6838&rft_id=info:doi/10.1016/S0272-6386(12)81122-X&rft_dat=%3Cproquest_cross%3E80443693%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80443693&rft_id=info:pmid/1992656&rft_els_id=S027263861281122X&rfr_iscdi=true |